VMA22 and hyperlipidemia: Compared with VMA21 deficiency (25% increase in LDL-c) and ATP6AP2 deficiency (on average 20% increase in LDL-c), the hyperlipidemia in TMEM199 and CCDC115 deficiency clearly was more pronounced (124% increase in LDL-c).